Antibodies in proteomics II: Screening, high-throughput characterization and downstream applications

Trends in Biotechnology

Volumn 21, Issue 7, 2003, Pages 312-317

  Bradbury, Andrew ^a   Velappan, Nileena ^a   Verzillo, Vittorio ^b   Ovecka, Milan ^a   Chasteen, Leslie ^a   Sblattero, Daniele ^c   Marzari, Roberto ^c   Lou, Jianlong ^b   Siegel, Robert ^d   Pavlik, Peter ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TRIESTE   (Italy)

^d PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDERS; CELLS; FLUORESCENCE; IMMUNOLOGY;

WESTERN BLOTTING;

ANTIBODIES;

ANTIBODY; PEPTIDE; RESTRICTION ENDONUCLEASE; TISSUE POLYPEPTIDE ANTIGEN;

ANTIBODY; BIOTECHNOLOGY; IMMUNIZATION;

CLINICAL PROTOCOL; COMMERCIAL PHENOMENA; DNA FINGERPRINTING; DOWNSTREAM PROCESSING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TARGETING; GENETIC PROCEDURES; GENETIC SELECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SCREENING; WESTERN BLOTTING;

EID: 10744220060     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00117-3     Document Type: Review

References (64)

1. Marks J.D., et al. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:1991;581-597.
2. de Wildt R.M., et al. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol. 18:2000;989-994.
3. Robinson W.H., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8:2002;295-301.
4. Haab B.B. Advances in protein microarray technology for protein expression and interaction profiling. Curr. Opin. Drug Discov. Devel. 4:2001;116-123.
5. Haab B.B., et al. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001;2. RESEARCH0004.
6. Bradbury A. Antibodies in proteomics 1: generating antibodies. Trends Biotechnol. 2003;21.
7. Lou J., et al. Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J. Immunol. Methods. 253:2001;233-242.
8. Pack P., Pluckthun A. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry. 31:1992;1579-1584.
9. Evan G.I., et al. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:1985;3610-3616.
10. Hanke T., et al. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J. Gen. Virol. 73:1992;653-660.
11. Pluckthun A., Pack P. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology. 3:1997;83-105.
12. Neri D., et al. High-affinity antigen binding by chelating recombinant antibodies (CRAbs). J. Mol. Biol. 246:1995;367-373.
13. Krebber A., et al. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J. Immunol. Methods. 201:1997;35-55.
14. Krebs B., et al. High-throughput generation and engineering of recombinant human antibodies. J. Immunol. Methods. 254:2001;67-84.
15. Griep R.A., et al. pSKAP/S: an expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins. Protein Expr. Purif. 16:1999;63-69.
16. Persic L., et al. Targeting vectors for intracellular immunisation. Gene. 187:1997;1-8.
17. Persic L., et al. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene. 187:1997;9-18.
18. Hartley J.L., et al. DNA cloning using in vitro site-specific recombination. Genome Res. 10:2000;1788-1795.
19. Reboul J., et al. Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans. Nat. Genet. 27:2001;332-336.
20. Siegel R.W., et al. Using an in vivo phagemid system to identify non-compatible loxP sequences. FEBS Lett. 505:2001;467-473.
21. Lee G., Saito I. Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene. 216:1998;55-65.
22. Hoess R.H., et al. The role of the loxP spacer region in P1 site-specific recombination. Nucleic Acids Res. 14:1986;2287-2300.
23. Sblattero D., Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries. Nat. Biotechnol. 18:2000;75-80.
24. Kononen J., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4:1998;844-847.
25. Keenan S.J., et al. An automated machine vision system for the histological grading of cervical intraepithelial neoplasia (CIN). J. Pathol. 192:2000;351-362.
26. van Zuijlen P.P., et al. Morphometry of dermal collagen orientation by Fourier analysis is superior to multi-observer assessment. J. Pathol. 198:2002;284-291.
27. Miller J.C., et al. The application of protein microarrays to serum diagnostics: prostate cancer as a test case. Dis. Markers. 17:2001;225-234.
28. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763.
29. Paweletz C.P., et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. 20:2001;1981-1989.
30. Sreekumar A., et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res. 61:2001;7585-7593.
31. Schweitzer B., et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 20:2002;359-365.
32. MacBeath G. Protein microarrays and proteomics. Nat. Genet. 32:(Suppl. 1):2002;526-532.
33. Xu L., et al. Directed evolution of high-affinity antibody mimics using mRNA display. Chem. Biol. 9:2002;933-942.
34. Borrebaeck C.A., et al. Protein chips based on recombinant antibody fragments: a highly sensitive approach as detected by mass spectrometry. BioTechniques. 30:2001;1126-1132.
35. Cattaneo A., Biocca S. Intracellular Antibodies: Developments and Applications. 1997;Landes Bioscience. distributed by Academic Press.
36. Biocca S., et al. Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of Xenopus oocytes. Biochem. Biophys. Res. Commun. 197:1993;422-427.
37. Gargano N., et al. Human recombinant antibody fragments neutralising human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family. J. Virol. 70:1996;7706-7712.
38. Gargano N., Cattaneo A. Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment. J. Gen. Virol. 78:1997;2591-2599.
39. Cardinale, A. et al. The mode of action of the Y13-259 scFv fragment when expressed intracellularly in mammalian cells. FEBS Lett. (in press).
40. Mhashilkar A.M., et al. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 14:1995;1542-1551.
41. Richardson J.H., et al. Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the α subunit of the receptor. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3137-3141.
42. Werge T.M., et al. Intracellular single chain Fv antibody inhibits Ras activity in T-cell antigen receptor stimulated Jurkat cells. FEBS Lett. 351:1994;393-396.
43. Lener M., et al. Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras. Eur. J. Biochem. 267:2000;1196-1205.
44. Marasco W.A., et al. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7889-7893.
45. Mhashilkar A.M., et al. Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes. Gene Ther. 9:2002;307-319.
46. Auf der Maur A. et al. Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework. J. Biol. Chem. (in press).
47. Zhu Q., et al. Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7. J. Immunol. Methods. 231:1999;207-222.
48. Ohage E., Steipe B. Intrabody construction and expression. I. The critical role of VL domain stability. J. Mol. Biol. 291:1999;1119-1128.
49. Visintin M., et al. The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies. J. Mol. Biol. 317:2002;73-83.
50. Ohage E.C., et al. Intrabody construction and expression. II. A synthetic catalytic Fv fragment. J. Mol. Biol. 291:1999;1129-1134.
51. Steipe B., et al. Sequence statistics reliably predict stabilizing mutations in a protein domain. J. Mol. Biol. 240:1994;188-192.
52. Wirtz P., Steipe B. Intrabody construction and expression III: engineering hyperstable V(H) domains. Protein Sci. 8:1999;2245-2250.
53. Bach H., et al. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. J. Mol. Biol. 312:2001;79-93.
54. Skerra A. Engineered protein scaffolds for molecular recognition. J. Mol. Recognit. 13:2000;167-187.
55. Nord K., et al. A combinatorial library of an α-helical bacterial receptor domain. Protein Eng. 8:1995;601-608.
56. Colas P., et al. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature. 380:1996;548-550.
57. Colas P., et al. Targeted modification and transportation of cellular proteins. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13720-13725.
58. Cohen B.A., et al. An artificial cell-cycle inhibitor isolated from a combinatorial library. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14272-14277.
59. Jacque J.M., et al. Modulation of HIV-1 replication by RNA interference. Nature. 418:2002;435-438.
60. Miyagishi M., Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20:2002;497-500.
61. Sui G., et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5515-5520.
62. Harborth J., et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114:2001;4557-4565.
63. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
64. Schweitzer B., Kingsmore S.F. Measuring proteins on microarrays. Curr. Opin. Biotechnol. 13:2002;14-19.